Zhejiang Jingxin Pharmaceutical Co., Ltd.
SZSE:002020.SZ
14.09 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Zhejiang Jingxin Pharmaceutical Co., Ltd. |
Symbool | 002020.SZ |
Munteenheid | CNY |
Prijs | 12.55 |
Beurswaarde | 10,805,913,850 |
Dividendpercentage | 2.51% |
52-weken bereik | 10.62 - 16.16 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jin Zhiping |
Website | https://www.jingxinpharm.com |
An error occurred while fetching data.
Over Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs, antihypertensive products, antibiotics, quinolones, gastrointestinal promotions, antidiabetics, antipileptics, antihistamines, H+ pump depressants, antihyper cholesterolemia products, histamine H2 receptor blokades, antihyper cholesterolemirs, antidepressants, cephalosporin products, and biopharma products. It also provides diagnostic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)